Warning letter
Queseria Chipilo, Inc. [ARCHIVED]: warning letter of Mar 3, 2011
FDA warning letter 148132 · New Jersey District Office
Key facts
| Reference number | 148132 |
|---|---|
| Company | Queseria Chipilo, Inc. [ARCHIVED] |
| Subject | CGMP For Manufacturing, Packing, or Holding Human Food/Adulterated/Insanitary Conditions |
| Issue date | Mar 3, 2011 |
| Posted date | Mar 3, 2011 |
| Issuing office | New Jersey District Office |
| Product type | Food/Cosmetics |
| CFR sections cited | 110.40(b), 110, 110.10(b), 110.10(b)(1), 110.10(b)(3), 110.10(c), 110.35(a), 110.35(c), 110.37(b)(3), 110.37(b)(4), 110.40(a), 110.80(a)(5) |
| Inspection city | Passaic |
| Inspection ZIP | 07055 |
| Inspection start date | Oct 25, 2010 |
| Letter on fda.gov | web.archive.org |
At a glance
- 10–99 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: